GHUCCTS

News

Share This
  • Feb 12, 2021

MedStar Health's COVID-19 Community Research Partnership

Join MedStar Health in learning more about COVID-19 in our Community. MedStar Health is conducting a real-time COVID-19 surveillance study to better understand COVID-19 spread and vaccine adoption within our community. If you are age 18 or older, we need YOU to help us improve COVID-19 prevention strategies that will benefit you, your family members, and the larger community. Go to MedStarHealth.org/JoinTheFight and click the button to sign up for the study. You only need to be over 18 years old and have an email address to be part of the study.

You can learn more about the project here.

Related News

Funding Opportunity: GHUCCTS 2021-2022 Pilot Awards

Mar 29, 2021

GHUCCTS is pleased to announce our 2021-2022 GHUCCTS Pilot Awards application cycle. Applicants must have a full-time faculty appointment at one of the GHUCCTS institutions (Howard, Georgetown, DCVA, Medstar, ORNL). Each application should identify a Contact PI who will be responsible for coordinating and submitting the application. Applications are due Monday, April 19, 2021.

Dr. Veronica Thomas co-authors textbook, named 2021 "Most Promising New Textbook" by TAA

Mar 22, 2021

The Textbook & Academic Authors Association (TAA) recently announced the recipients of their 2021 Textbook Awards. "Evaluation in Today's World:  Respecting Diversity, Improving Quality, and Promoting Usability", co-authored by GHUCCTS Evaluation & Continuous Improvement Director Dr. Veronica Thomas, was one of ten textbooks to receive the "Most Promising New Textbook" award.

Recruitment Innovation Center develops COVID-19 Recruitment + Retention Toolkit

Mar 11, 2021

The Recruitment Innovation Center (RIC) has been heavily involved in multisite COVID-19 trial design and implementation, having consulted on 29 COVID-19 related studies as of this writing. While striving to maintain its values of community engagement, participant-informed methods and scalable design, the RIC has developed new tools and strategies that work in this transformed clinical trial space.

Close